• Debate Pack

    A New Cancer Strategy

    A debate on a motion relating to a new cancer strategy has been scheduled by the Backbench Business Committee following a bid from John Baron, Jo Churchill and David Tredinnick. John Baron, Conservative MP for Basildon and Billericay will open the debate.

  • Research Briefing

    Cancer Statistics: In Detail

    How has the prevalence of cancer in the UK changed over time? How does it vary between different UK countries and regions? Which cancers are most common? How do mortality rates vary by age and location? How do survival rates vary between cancers?

  • Research Briefing

    Cancer: Waiting Times for Diagnosis and Treatment

    How long do patients wait for cancer diagnosis and treatment? This note outlines NHS performance trends relating to cancer testing, treatment and care. In 2014 there were 1.5m urgent GP referrals with suspected cancer. This is 53% higher than in 2010. 272,000 patients began treatment for cancer, up 12% on 2010. Of these, 129,000 had previously been urgently referred by their GP, up 25% on 2010.

  • Research Briefing

    Mitochondrial Donation

    This note seeks to provide a summary of the role of mitochondria, mitochondrial disease and the proposed new techniques. It will also outline the investigations into these techniques that took place prior to the Government announcement; a HFEA scientific review of the safety and efficacy of methods, an ethical review of the techniques for mitochondrial replacement undertaken by the Nuffield Council on Bioethics and an HFEA public consultation. The main safety and ethical considerations associated with the introduction of these techniques into clinical practice will be discussed.

  • Research Briefing

    Asbestos-related diseases: payments from the Department for Work and Pensions

    Exposure to asbestos fibres can lead to a number of serious diseases. People suffering from certain conditions may be able to pursue a civil claim for damages against one or more employers responsible for exposing them to asbestos negligently and/or in breach of a statutory duty. Compensation may also be available under schemes administered by the Department for Work and Pensions (DWP).

  • Research Briefing

    Mesothelioma Bill [HL]: House of Commons stages

    The Mesothelioma Bill [HL] establishes a new Diffuse Mesothelioma Payment Scheme to make payments to people with diffuse mesothelioma who were exposed to asbestos either negligently or in breach of statutory duty by an employer, and who are unable to bring a claim for damages against the employer or an Employers’ Liability (EL) insurer.

  • Research Briefing

    Mesothelioma Bill

    The Bill provides the legislative framework for a new Diffuse Mesothelioma Payment Scheme to make payments to people with diffuse mesothelioma who were exposed to asbestos either negligently or in breach of statutory duty by an employer, and who are unable to bring a claim for damages against the employer or an Employers’ Liability (EL) insurer.

  • Research Briefing

    Nuclear test veterans – compensation

    A group of 1,011 services veterans and civilians from the UK, Fiji and New Zealand have attempted to obtain a compensation hearing against the Ministry of Defence relating to alleged illnesses caused by exposure to radiation in nuclear weapons tests during the 1950s. However, in March 2012 the Supreme Court ruled against the Atomic Veterans’ case proceeding and the Government says it has no plans to pay compensation.

  • Research Briefing

    HIV and AIDS statistics: UK

    HIV and AIDS statistics: UK. By Rachael Harker. SN/SG/2210. This note summarises recent statistics on Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and also includes a POSTBOX on HIV Infection and Treatment. Section 1 describes how the numbers of those diagnosed with and those dying from HIV/AIDS in the UK have changed over time. The characteristics that put people most at risk of HIV are considered in Sections 2 and the manner and place in which individuals with HIV acquire their infection in examined in Section 3. The general prevalence of HIV, and levels of awareness of infection, are examined in Section 4. International statistics on HIV and AIDS are briefly considered in Section 5, while Section 6 looks at public knowledge and attitudes to the disease.

  • Research Briefing

    HIV and Hepatitis C infection from contaminated blood and blood products

    This Note summarises the background and current areas of debate relating to an episode of HIV and Hepatitis C infection from contaminated blood and blood products during the 1970s and 1980s. This includes existing support for those affected, the recommendations of an independent inquiry on this matter (the Archer Inquiry), and ongoing debate relating to levels of support in comparison with other countries.